APA
Manso L., Palomo A. G., Pérez Carrión R., Cassinello J., Gallegos Sancho I., Chacón López-Muñiz I., Olier C., Fernández-Aramburo A., Llorca C., González X., Llorente R., Torregrosa D., Álvarez I., Gálve E., Bueno C., Garau I., García M. J., González-Santiago S., Ballesteros A. I., Blanco E., Galán A., González S., Perelló A., Cortés-Funes H. & Grávalos C. (20160331). Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. : Anticancer research.
Chicago
Manso Luís, Palomo Andrés García, Pérez Carrión Ramón, Cassinello Javier, Gallegos Sancho Isabel, Chacón López-Muñiz Ignacio, Olier Clara, Fernández-Aramburo Antonio, Llorca Cristina, González Xavier, Llorente Rosa, Torregrosa Dolores, Álvarez Iñaki, Gálve Elena, Bueno Coralia, Garau Isabel, García María José, González-Santiago Santiago, Ballesteros Ana Isabel, Blanco Esperanza, Galán Antonio, González Sonia, Perelló Antonia, Cortés-Funes Hernán and Grávalos Cristina. 20160331. Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. : Anticancer research.
Harvard
Manso L., Palomo A. G., Pérez Carrión R., Cassinello J., Gallegos Sancho I., Chacón López-Muñiz I., Olier C., Fernández-Aramburo A., Llorca C., González X., Llorente R., Torregrosa D., Álvarez I., Gálve E., Bueno C., Garau I., García M. J., González-Santiago S., Ballesteros A. I., Blanco E., Galán A., González S., Perelló A., Cortés-Funes H. and Grávalos C. (20160331). Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. : Anticancer research.
MLA
Manso Luís, Palomo Andrés García, Pérez Carrión Ramón, Cassinello Javier, Gallegos Sancho Isabel, Chacón López-Muñiz Ignacio, Olier Clara, Fernández-Aramburo Antonio, Llorca Cristina, González Xavier, Llorente Rosa, Torregrosa Dolores, Álvarez Iñaki, Gálve Elena, Bueno Coralia, Garau Isabel, García María José, González-Santiago Santiago, Ballesteros Ana Isabel, Blanco Esperanza, Galán Antonio, González Sonia, Perelló Antonia, Cortés-Funes Hernán and Grávalos Cristina. Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. : Anticancer research. 20160331.